Table 3.

Unadjusted and adjusted analysis of age, gender, race, patient interval and diagnostic interval related to the odds of having received up front surgical treatment for PDAC

Risk factor	No upfront surgery (n=78)	Upfront surgery (n=38)	Unadjusted odds ratio (95% CI)	P value	Adjusted odds ratio (95% CI)	Adjusted P value
Age at 1st medical, median [IQR] (years)	64 [57–70]	67 [54–76]	1.01 (0.97–1.05)	0.480	1.00 (0.96–1.05)	0.850
Male, n [%]	45 [58]	21 [55]	0.91 (0.41–2.00)	0.800	0.91 (0.36–2.24)	0.830
Non-white, n [%]	21 [27]	1 [3]	0.07 (0.004–0.380)	0.012	0.09 (0.004–0.480)	0.023
Diagnosis ≤60 days, n [%]	23 [29]	37 [97]	15.47 (3.04–283.00)	0.009	15.68 (2.95–291.00)	0.009
Medical visit ≤30 days, n [%]	55 [71]	34 [89]	3.55 (1.23–12.91)	0.030	3.41 (1.08–13.20)	0.050

PDAC, pancreatic ductal adenocarcinoma; IQR, interquartile range; CI, confidence interval.